LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
+6.47%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.15B
AUM Growth
+$1.15B
(-8.4%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-12.59%
Top 10 Holdings %
Top 10 Hldgs %
19.03%
Holding
431
New
73
Increased
185
Reduced
111
Closed
35
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$14.2M |
| 2 |
Evolent Health
EVH
|
$9.74M |
| 3 |
Royal Caribbean
RCL
|
$8.6M |
| 4 |
argenx
ARGX
|
$7.09M |
| 5 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$6.55M |
Top Sells
| 1 |
CIXX
CI Financial Corp.
CIXX
|
$27M |
| 2 |
KE Holdings
BEKE
|
$15.7M |
| 3 |
Huazhu Hotels Group
HTHT
|
$15.4M |
| 4 |
Abbott
ABT
|
$15M |
| 5 |
Pfizer
PFE
|
$14.1M |
Sector Composition
| 1 | Healthcare | 44.36% |
| 2 | Consumer Discretionary | 13.29% |
| 3 | Technology | 13.16% |
| 4 | Financials | 10.68% |
| 5 | Industrials | 6.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Manulife Financial
MFC
$52.2B
| $30.3M | 2.65% | 906,314 -297,956 | -25% | -$9.98M |
|
2
DexCom
DXCM
$29.5B
| $27.2M | 2.38% | 234,291 +19,500 | +9% | +$2.27M |
|
3
IQVIA
IQV
$32.4B
| $22.5M | 1.97% | 113,252 -9,766 | -8% | -$1.94M |
|
4
Service Corp International
SCI
$11.1B
| $22M | 1.92% | 320,000 -75,000 | -19% | -$5.16M |
|
5
Thermo Fisher Scientific
TMO
$186B
| $22M | 1.92% | 38,134 -9,505 | -20% | -$5.48M |
|
6
Apple
AAPL
$3.45T
| $21.7M | 1.89% | 131,469 +11,975 | +10% | +$1.97M |
|
7
Insulet
PODD
$23.9B
| $19M | 1.66% | 59,680 +17,057 | +40% | +$5.44M |
|
8
InMode
INMD
$944M
| $18.1M | 1.58% | 566,557 +50,000 | +10% | +$1.6M |
|
9
Merck
MRK
$210B
| $17.9M | 1.56% | 167,830 -14,122 | -8% | -$1.5M |
|
10
UnitedHealth
UNH
$281B
| $17.3M | 1.51% | 36,654 +735 | +2% | +$347K |
|
11
Microsoft
MSFT
$3.77T
| $16.8M | 1.47% | 58,272 +6,724 | +13% | +$1.94M |
|
12
Brunswick
BC
$4.15B
| $16.4M | 1.43% | 200,000 -100,000 | -33% | -$8.2M |
|
13
Lowe's Companies
LOW
$145B
| $16.2M | 1.42% | 81,235 -13,090 | -14% | -$2.62M |
|
14
Hologic
HOLX
$14.9B
| $16.2M | 1.42% | 201,280 -19,434 | -9% | -$1.57M |
|
15
Bristol-Myers Squibb
BMY
$96B
| $16.2M | 1.42% | 234,262 -8,971 | -4% | -$622K |
|
16
Labcorp
LH
$23.1B
| $16.2M | 1.42% | 70,683 -5,033 | -7% | -$1.15M |
|
|
SWAV
17
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $15.8M | 1.38% | 72,904 +30,187 | +71% | +$6.55M |
|
18
Eli Lilly
LLY
$657B
| $15.6M | 1.36% | 45,426 +16,903 | +59% | +$5.8M |
|
19
Keysight
KEYS
$28.1B
| $15.4M | 1.35% | 95,522 -3,710 | -4% | -$599K |
|
20
Alnylam Pharmaceuticals
ALNY
$58.5B
| $15.2M | 1.33% | 76,103 +19,365 | +34% | +$3.88M |
|
21
BioMarin Pharmaceuticals
BMRN
$11.2B
| $15.1M | 1.32% | 155,411 -50,802 | -25% | -$4.94M |
|
22
American Express
AXP
$231B
| $15M | 1.31% | 90,720 -29,006 | -24% | -$4.78M |
|
|
23
Vertex Pharmaceuticals
VRTX
$100B
| $15M | 1.31% | 47,485 +44,951 | +1,774% | +$14.2M |
|
24
Equity Lifestyle Properties
ELS
$11.7B
| $14.6M | 1.27% | 217,232 -7,925 | -4% | -$532K |
|
25
Ameriprise Financial
AMP
$48.5B
| $14M | 1.22% | 45,702 -35,000 | -43% | -$10.7M |
|